Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,374 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06422208Enrolling by invitationPhase 1
Parkinson's cell transplant trial using your own cells
This trial tests whether transplanting special dopamine-producing cells made from a patient's own skin cells can help treat Parkinson's disease. It is for people who have had Parkinson's for at least 5 years and still respond well to medication.
Boston, MassachusettsAges 55–80 - NCT06439862Recruiting
Quality of life in children with posterior urethral valves
This study looks at how children with posterior urethral valves (a condition that affects urination) feel about their quality of life as they grow up. It will help doctors understand how these children are doing emotionally and socially, so they can improve care.
Bron, BronAges 6–17 - NCT06434207Recruiting
Heart defect study in newborns to understand blood clots
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
Boston, MassachusettsAges 1 day–1 week - NCT06432582Recruiting
Liver disease blood marker study for people with stiff livers
This study looks at whether certain micro-RNA levels in your blood can help predict how your chronic liver disease is progressing. It is for people who already have some liver stiffness (measured by a special ultrasound) and are being treated at the University Hospital St. Pölten.
Sankt Pölten, Lower AustriaAges 18 years+ - NCT06439992Recruiting
New PET scan tracer to detect Alzheimer's in the brain
This study tests a new PET imaging tracer called Fluselenamyl to see how well it shows amyloid plaques (a protein linked to Alzheimer's) in the brain. It may help improve early diagnosis for people with Alzheimer's or support research in healthy volunteers.
St Louis, MissouriAges 18 years+ - NCT06431633RecruitingPhase 3
Sacituzumab and zimberelimab for lung cancer after surgery
This trial tests a combination of two drugs (sacituzumab and zimberelimab) for people with non-small cell lung cancer that was confined to the chest, was surgically removed, but not completely cleared by prior chemotherapy and immunotherapy. The goal is to see if this treatment can help prevent the cancer from coming back.
Alicante, AlicanteAges 18 years+ - NCT06439082RecruitingPhase 3
Crizanlizumab for sickle cell pain crises
This trial tests whether crizanlizumab can reduce painful sickle cell crises (called vaso-occlusive crises or VOCs) in people with sickle cell disease who have frequent crises. It may be an option for those who still have crises despite current treatments.
Birmingham, AlabamaAges 12–100 - NCT06430801RecruitingPhase 3
Study of tulisokibart for moderate to severe Crohn's disease
This trial tests a new medicine called tulisokibart for people with moderate to severe Crohn's disease. The medicine may help reduce inflammation and improve symptoms. It is for those who have not had success with other treatments.
Dothan, AlabamaAges 16–80 - NCT06405087RecruitingPhase 3
Long-term study of vedolizumab for children with IBD
This study is for children and teenagers with ulcerative colitis or Crohn's disease who have already completed a previous vedolizumab study and are doing well. It will look at the long-term safety and effectiveness of continuing vedolizumab treatment.
Phoenix, ArizonaAges 2–17 - NCT06405334Recruiting
Balance and movement study for veterans with Parkinson's
This study looks at how Parkinson's disease affects balance and movement. It may help predict fall risk and improve care. Some participants also have a special brain device to help with movement.
Minneapolis, MinnesotaAges 18 years+ - NCT06399822Recruiting
Capillaroscopy for managing undifferentiated connective tissue disease
This study looks at whether a simple test called capillaroscopy (which examines tiny blood vessels in your fingernails) can help doctors better manage undifferentiated connective tissue disease. If you join, the test results will be used to guide your care, and researchers will see how it affects treatment decisions.
Québec, QuebecAges 18 years+ - NCT06416072Enrolling by invitation
Blood marker study for people not eligible for Alzheimer's prevention trials
This study looks at blood markers in people who were part of an early Alzheimer's prevention study but did not qualify for it because their amyloid levels were too low. It aims to understand brain changes and possibly find ways to detect Alzheimer's even earlier.
Birmingham, AlabamaAges 55–80 - NCT06408961Recruiting
EVs in Obesity and Cardiometabolic Disease
This study looks at tiny particles released by cells (called extracellular vesicles, or EVs) in people with obesity and related heart health issues. Researchers want to see if these particles are different in people with obesity and diabetes, which could help find new ways to treat or prevent heart problems.
Boston, MassachusettsAges 18 years+ - NCT06399900Recruiting
Light therapy plus exercise for better walking with PAD
This study tests whether adding light therapy to a walking program helps people with peripheral artery disease (PAD) walk further and feel better. You'll receive either light therapy or a placebo light while doing a supervised exercise program.
Chicago, IllinoisAges 50 years+ - NCT06414967Recruiting
Music therapy for irritability in Huntington's disease
This study tests if music therapy can help reduce irritability and impulsivity in people with Huntington's disease. You'll participate in music sessions to see if it improves your mood and behavior.
PoitiersAges 18 years+ - NCT06409585Recruiting
Heart muscle disease imaging study for scarring
This study uses advanced imaging (PET/MR or PET/CT) to look at scarring (fibrosis) in the heart muscle. It is for people with various heart muscle diseases, including heart failure with preserved pumping, thickened heart muscle, high blood pressure-related heart damage, heart inflammation, and others.
Edinburgh, ScotlandAges 30–90 - NCT06410144Recruiting
Education study for older adults with kidney disease
This study tests a program to help older adults with advanced kidney disease learn about their treatment options before deciding on dialysis. It is designed for those who have not yet made a decision.
Brockport, New YorkAges 75 years+ - NCT06399809RecruitingPhase 2
Fisetin for better walking in peripheral artery disease
This study tests whether a supplement called fisetin can help reduce leg pain and improve walking ability in people with peripheral artery disease (PAD). If you have PAD and are 50 or older, you may be able to join and help see if fisetin can make walking easier.
Chicago, IllinoisAges 50 years+ - NCT06402955RecruitingPhase 2
Imaging depression in Parkinson's disease
This study uses brain imaging (PET scans) to understand depression in people with Parkinson's disease. It may also test a depression treatment called ketamine, but the main goal is to see how the brain changes with depression.
New Haven, ConnecticutAges 40–80 - NCT06406621Recruiting
Laser hair removal to prevent pilonidal disease in darker skin
This study tests whether laser hair removal can help prevent pilonidal disease from coming back in people with darker skin. It is designed for teenagers and young adults who have had pilonidal disease but are not currently having a flare-up.
Wilmington, DelawareAges 10–21 - NCT06416345Recruiting
Cue2Walk: Freezing detection and cues for Parkinson's walking
This study tests whether a new device called Cue2Walk can help people with Parkinson's disease who have freezing of gait. The device detects when you freeze and sends a signal (like a beep) to help you start walking again. Researchers want to see if it is worth the cost compared to your usual care.
Nijmegen, GelderlandAges Any age - NCT06416371Recruiting
Eye vessel leakage study for mild stroke survivors
This study uses eye scans to see if blood vessel leakage in the retina (back of the eye) is linked to small vessel disease in the brain after a mild stroke. It may help doctors better understand and monitor this condition.
EdinburghAges 18 years+ - NCT00267501Recruiting
Study collects data and samples to understand eosinophilic conditions
This study collects information and biological samples to better understand what causes certain allergic/eosinophilic conditions. It may help researchers learn mechanisms and improve future care.
Cincinnati, OhioAges Any age - NCT03949972Recruiting
FSGS and MCD patient registry for kidney disease
This study is a registry that collects medical information from people with nephrotic syndrome caused by FSGS or minimal change disease (MCD). It may help doctors better understand these conditions and improve future care, especially by tracking patients over time.
Cologne, North Rhine-WestphaliaAges Any age
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,374 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.